Indraprastha Medical Corporation Ltd (INDRAMEDCO) is currently trading at 334.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Indraprastha Medical Corporation Limited provides high-quality, comprehensive hospital services, enhancing patients' quality of life. The company has established India's first corporate hospital, a multi-disciplinary super-speciality tertiary care hospital in New Delhi. Recent advancements include robotic surgeries, complex transplants, and unique procedures like 3D-assisted surgeries and innovative cancer treatments. The hospital continues to innovate, highlighted by breakthroughs like the first robotic hip replacement in North India and Zap-X radiosurgery. A strong focus on infrastructure enhancements and patient experience is evident, with several new clinical services and significant technology investments.

Over the past 52 weeks, Indraprastha Medical Corporation Ltd has traded between a low of ₹293.50 and a high of ₹640.05. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Indraprastha Medical Corporation Ltd has a market capitalization of approximately 2,926.20. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Indraprastha Medical Corporation Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 15.23 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 2,926.20 Cr, Indraprastha Medical Corporation Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Indraprastha Medical Corporation Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Indraprastha Medical Corporation Ltd is 15.23. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The supplied earnings calendar lists October 29, 2026, as the Q2 FY27 results date. Investors should confirm the final timing through the company’s exchange filing.

The board meeting is scheduled for Tuesday, May 12, 2026.